Neuphoria Therapeutics, Inc. (NEUP)
3.86
-0.03
(-0.77%)
USD |
NASDAQ |
Dec 19, 10:17
Neuphoria Therapeutics Shareholders Equity (Quarterly): 12.51M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Adverum Biotechnologies, Inc. | -55.65M |
| Aditxt, Inc. | -7.733M |
| Recursion Pharmaceuticals, Inc. | 1.047B |
| X4 Pharmaceuticals, Inc. | 61.62M |
| Inhibrx Biosciences, Inc. | 36.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.34M |
| Total Liabilities (Quarterly) | 14.83M |
| Debt to Equity Ratio | 0.0094 |
| Current Ratio | 2.723 |
| Net Debt Paydown Yield | -0.11% |